This NDC is on FDA's drug shortage list (posted Feb 8, 2019)
Product Information
DEXAMETHASONE 4 MG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.6719 per ML under NDC 00641614525. Its NADAC has been published 236 times since Jul 24, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
4 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641614525
Classification
Generic
Dosage Form
INJECTION
Route
INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE
Effective Date
8/19/2026
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA084282FDA Approved
Before 1982
TE Code
AP
On Market Since
7/15/1975
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 4 MG/ML VIAL has been published 236 times since Jul 24, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6719 per ML |
|---|---|
| All-time high | $1.3879 (Sep 15, 2021) |
| All-time low | $0.5860 (Apr 22, 2020) |
| 52-week high | $0.8198 |
| 52-week low | $0.6575 |
| Median price | $0.7743 |
| Average price | $0.8737 |
| Largest weekly change | +136.8% (Sep 23, 2020) |
| Weeks tracked | 236 |
| Tracking since | Jul 24, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 4 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 4 MG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.6719 per ML (NDC 00641614525), effective Aug 19, 2026.
How has the price of DEXAMETHASONE 4 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 4 MG/ML VIAL has held within roughly two percent of its current level. It has been tracked across 236 weekly CMS publications since Jul 24, 2019.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 4 MG/ML VIAL?
Since Jul 24, 2019, the NADAC for DEXAMETHASONE 4 MG/ML VIAL has ranged from a low of $0.5860 (Apr 22, 2020) to a high of $1.3879 (Sep 15, 2021), with a median of $0.7743 per ML.
Are there cheaper alternatives to DEXAMETHASONE 4 MG/ML VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 20 MG/5 ML VIAL, is $0.2014 per ML — about 70% below DEXAMETHASONE 4 MG/ML VIAL.
Who manufactures DEXAMETHASONE 4 MG/ML VIAL?
DEXAMETHASONE 4 MG/ML VIAL (NDC 00641614525) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is DEXAMETHASONE 4 MG/ML VIAL in shortage?
Yes — NDC 00641614525 is currently listed in FDA's drug shortage database (posted Feb 8, 2019).